Mounjaro & Pancreatitis UK: Safety Guide | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro and Pancreatitis - UK Price £124.99

Get Mounjaro at the cheapest UK price from £124.99 plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Your Mounjaro And Pancreatitis Questions Answered

Published on: June 03, 2026

If you're researching mounjaro and pancreatitis uk safety information, you're taking the right precautions. Mounjaro (tirzepatide) is contraindicated in patients with a history of acute pancreatitis, and UK prescribers must carefully assess pancreatic risk factors before prescribing. At Cured Pharmacy, our clinical team evaluates every patient's medical history to ensure safe, appropriate treatment selection.

Understanding Mounjaro and Pancreatitis Risk

Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist that has been associated with rare cases of acute pancreatitis in clinical trials [1]. The SURPASS trial programme reported pancreatitis in approximately 0.2% of tirzepatide-treated patients compared to 0.1% in placebo groups, though the difference was not statistically significant [1].

The mechanism linking GLP-1 receptor agonists to pancreatitis remains unclear, but the MHRA advises that patients with a history of pancreatitis should not use Mounjaro [2]. UK prescribers are required to screen for pancreatic disease history during clinical assessment, and any patient reporting previous pancreatitis episodes will typically be deemed unsuitable for tirzepatide therapy.

Symptoms of acute pancreatitis include severe persistent abdominal pain, often radiating to the back, accompanied by nausea and vomiting. If you experience these symptoms whilst taking Mounjaro, you must stop the medication immediately and seek urgent medical attention [2].

Can You Take Mounjaro with a History of Pancreatitis?

No — Mounjaro is contraindicated in patients with a personal history of acute or chronic pancreatitis. This is an absolute contraindication listed in the UK Summary of Product Characteristics, meaning UK prescribers cannot legally prescribe tirzepatide to anyone who has experienced pancreatitis previously [2].

During your online consultation at Cured Pharmacy, you will be asked specifically about pancreatic disease history. Our UK prescribers, working under the clinical governance of superintendent pharmacist Tarun Kumar (GPhC 2233073), will decline Mounjaro prescriptions for any patient reporting previous pancreatitis, regardless of how long ago the episode occurred.

This precaution applies equally to all GLP-1 receptor agonists licensed in the UK, including semaglutide-based treatments. If you have pancreatitis history, alternative weight loss medications with different mechanisms of action may be more appropriate.

Risk Factors That May Exclude You from Mounjaro

Beyond previous pancreatitis, UK prescribers assess additional risk factors including gallstones (cholelithiasis), hypertriglyceridaemia above 500 mg/dL, and chronic alcohol consumption — all of which increase pancreatitis risk [3]. Patients with these conditions may be advised to pursue alternative weight management strategies or address underlying risk factors before considering GLP-1 therapy.

Mounjaro and Pancreatitis UK Clinical Evidence

The SURPASS-1 through SURPASS-5 trials enrolled over 6,000 patients across multiple tirzepatide doses. Pooled safety data showed 11 cases of acute pancreatitis among tirzepatide-treated patients (0.19%) versus 2 cases in comparator groups (0.11%) [1]. Whilst the absolute risk remains low, the MHRA determined the evidence sufficient to warrant a contraindication for patients with pancreatitis history.

Post-marketing surveillance data from the United States, where tirzepatide launched earlier, has not revealed pancreatitis rates exceeding those observed in clinical trials. However, real-world data collection continues, and UK healthcare professionals are encouraged to report any suspected pancreatitis cases via the Yellow Card scheme [2].

It's important to note that obesity itself is an independent risk factor for acute pancreatitis, with studies showing a 1.5 to 3-fold increased risk in individuals with BMI above 30 kg/m² [4]. This creates a complex clinical picture where the underlying condition being treated may itself contribute to pancreatic risk.

Recognising Pancreatitis Symptoms on Mounjaro

Patients prescribed Mounjaro should be counselled to recognise pancreatitis warning signs: severe upper abdominal pain that may radiate to the back, nausea, vomiting, and abdominal tenderness. These symptoms typically develop suddenly and persist, distinguishing them from the common gastrointestinal side effects (mild nausea, occasional vomiting) that often resolve within weeks of starting treatment [2].

Treatment Mechanism Pancreatitis Risk Starting Price
Mounjaro (tirzepatide) GLP-1/GIP agonist Contraindicated with history From £124.99
Wegovy (semaglutide) GLP-1 agonist Contraindicated with history From £69.00
Saxenda (liraglutide) GLP-1 agonist Contraindicated with history From £68.00
Orlistat Lipase inhibitor Generally safe From £32.00
Xenical (orlistat) Lipase inhibitor Generally safe From £32.00

Alternative Weight Loss Treatments for Patients with Pancreatitis History

If you have a history of pancreatitis, you are not suitable for any GLP-1 receptor agonist, including Mounjaro, Wegovy, or Saxenda. However, alternative prescription weight loss medications with different mechanisms may be appropriate, subject to clinical assessment by a UK prescriber.

Orlistat (available as generic formulations or branded Xenical) works by inhibiting pancreatic and gastric lipases, reducing dietary fat absorption by approximately 30% [5]. Crucially, orlistat does not stimulate the pancreas or affect GLP-1 pathways, making it a safer option for patients with pancreatic disease history. Clinical trials demonstrated average weight loss of 2.9 kg more than placebo over one year when combined with dietary modification [5].

Mysimba (naltrexone/bupropion combination) acts centrally on appetite regulation centres in the hypothalamus and does not directly affect pancreatic function [6]. This medication may be considered for patients with pancreatitis history, though individual assessment of contraindications (including seizure disorders and uncontrolled hypertension) is required.

Scientific References

  1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
  3. Tenner, S., Baillie, J., DeWitt, J., & Vege, S. S. (2013). American College of Gastroenterology Guideline: Management of Acute Pancreatitis. American Journal of Gastroenterology, 108(9), 1400–1415. https://doi.org/10.1038/ajg.2013.218 [accessed 13 August 2026]
  4. Sadr-Azodi, O., Orsini, N., Andrén-Sandberg, Å., & Wolk, A. (2013). Abdominal and Total Adiposity and the Risk of Acute Pancreatitis: A Population-Based Prospective Cohort Study. American Journal of Gastroenterology, 108(1), 133–139. https://doi.org/10.1038/ajg.2012.381 [accessed 13 August 2026]
  5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
  6. Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595–605. https://doi.org/10.1016/S0140-6736(10)60888-4 [accessed 13 August 2026]
  7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. If you experience symptoms of pancreatitis (severe abdominal pain, nausea, vomiting), stop your medication and seek urgent medical attention.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can you take Mounjaro if you've had pancreatitis?
No. Mounjaro is contraindicated in patients with any history of acute or chronic pancreatitis, and UK prescribers cannot legally prescribe tirzepatide to anyone with previous pancreatic inflammation.
What are the signs of pancreatitis on Mounjaro?
Severe persistent upper abdominal pain (often radiating to the back), nausea, vomiting, and abdominal tenderness. If you experience these symptoms, stop Mounjaro immediately and seek urgent medical attention.
How common is pancreatitis with Mounjaro and pancreatitis UK data?
Clinical trials reported acute pancreatitis in approximately 0.2% of tirzepatide-treated patients, though this rate was not significantly higher than placebo groups. The absolute risk remains low but warrants precautionary contraindication.
Does Mounjaro cause pancreas problems?
Mounjaro has been associated with rare cases of acute pancreatitis in clinical trials, though causality has not been definitively established. UK prescribers screen for pancreatic risk factors before prescribing.
Can I take Wegovy or Saxenda if I've had pancreatitis?
No. All GLP-1 receptor agonists (including Wegovy, Saxenda, and Ozempic) share the same contraindication for patients with pancreatitis history.
What weight loss medication is safe with pancreatitis history?
Orlistat-based treatments (generic orlistat, Xenical, Alli, Orlos) work via lipase inhibition and do not affect pancreatic GLP-1 pathways, making them generally safer alternatives subject to prescriber assessment.
Will my online consultation ask about mounjaro and pancreatitis uk concerns?
Yes. Every Cured Pharmacy consultation includes specific questions about pancreatic disease history, and our UK prescribers will decline Mounjaro prescriptions for any patient reporting previous pancreatitis episodes.
How long after pancreatitis can you take Mounjaro?
There is no safe waiting period — pancreatitis history is a permanent contraindication to Mounjaro and all GLP-1 receptor agonists, regardless of how long ago the episode occurred.
Can Mounjaro cause pancreatitis in UK patients?
Mounjaro has been associated with rare cases of pancreatitis in clinical studies. If you have a history of pancreatitis, inform your Cured Pharmacy prescriber during consultation, as this may affect your suitability for treatment. Always report severe abdominal pain immediately to your healthcare provider.
Should I stop taking Mounjaro if I've had pancreatitis before?
Patients with a history of pancreatitis should discuss this with their prescriber before starting Mounjaro. Cured Pharmacy's UK-registered clinicians will assess your individual risk factors during your online consultation. Your previous medical history is essential for determining whether Mounjaro is safe for you.
What are the warning signs of pancreatitis on Mounjaro?
Warning signs include severe stomach pain that may radiate to your back, nausea, vomiting, and fever. If you experience these symptoms while taking Mounjaro from Cured Pharmacy, stop your injection and seek immediate medical attention. Early recognition and treatment of pancreatitis are crucial.
Is Mounjaro safe if I have a family history of pancreatitis?
A family history of pancreatitis should be disclosed during your Cured Pharmacy consultation. While it may increase your risk, it doesn't automatically disqualify you from treatment. Our UK prescribers will evaluate your complete medical profile to make an informed decision about your suitability for Mounjaro.
How does Cured Pharmacy monitor pancreatitis risk with Mounjaro?
Cured Pharmacy's ongoing care includes monitoring for adverse effects including pancreatitis symptoms. Our prescribers review your progress at each dose escalation and encourage you to report any concerning symptoms immediately. We provide clear guidance on warning signs to watch for throughout your Mounjaro treatment.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.